Parkman Healthcare Partners LLC Fulcrum Therapeutics, Inc. Transaction History

Parkman Healthcare Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$5.01 - $8.35 $142,880 - $238,133	-28,519 Reduced 12.12%	206,866 $1.51 Million
Q3 2022 Nov 14, 2022	SELL	$4.92 - $9.1 $134,335 - $248,466	-27,304 Reduced 10.39%	235,385 $1.9 Million
Q2 2022 Aug 12, 2022	BUY	$4.2 - $24.0 $412,591 - $2.36 Million	98,236 Added 59.74%	262,689 $1.29 Million
Q1 2022 May 13, 2022	SELL	$9.96 - $23.65 $853,103 - $2.03 Million	-85,653 Reduced 34.25%	164,453 $3.89 Million
Q4 2021 Feb 11, 2022	SELL	$14.0 - $28.44 $1.24 Million - $2.52 Million	-88,690 Reduced 26.18%	250,106 $4.42 Million
Q3 2021 Nov 12, 2021	BUY	$7.28 - $30.97 $1.4 Million - $5.96 Million	192,407 Added 131.44%	338,796 $9.56 Million
Q2 2021 Aug 13, 2021	BUY	$8.09 - $12.0 $167,066 - $247,812	20,651 Added 16.42%	146,389 $1.53 Million
Q1 2021 May 14, 2021	BUY	$10.94 - $15.32 $1.38 Million - $1.93 Million	125,738 New	125,738 $1.48 Million

148

51.9M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $220M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.